A prospective study of the PSMA-targeted radiotracer 18F-DCFPyL for the detection of tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Thyroid cancer
- Focus Diagnostic use; Proof of concept
- 19 Aug 2021 New trial record